Przejdź do zawartości
Merck

Role of transient receptor potential vanilloid 1 in regulating erythropoietin-induced activation of endothelial nitric oxide synthase.

Acta physiologica (Oxford, England) (2016-05-28)
Y-B Yu, K-H Su, Y R Kou, B-C Guo, K-I Lee, J Wei, T-S Lee
ABSTRAKT

Erythropoietin (EPO), the key hormone involved in erythropoiesis, beneficially affects endothelial cells (ECs), but the detailed mechanisms are yet to be completely understood. In this study, we investigated the role of transient receptor potential vanilloid type 1 (TRPV1), a ligand-gated non-selective calcium (Ca In ECs, EPO time dependently increased intracellular levels of calcium; this increase was abrogated by the Ca These findings indicate the EPO-induced Ca

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
MISSION® esiRNA, targeting human ARHGAP4
Sigma-Aldrich
Capsazepine, ≥98% (HPLC), solid